Literature DB >> 1942641

Prevention of the febrile reaction occurring on reinfusion of cell-free and concentrated autogenous ascites.

S Katoh1, H Tatsukawa, M Kondoh, M Inoue, K Ida, F Miyagawa.   

Abstract

The febrile reaction that occurs on reinfusion of ascites was studied. Intravenous reinfusion of ascites was performed 213 times in 63 cases of ascites, which were refractory to treatment with various drugs including diuretics. In order to prevent fever on reinfusion of ascites, a screen filter and a depth filter were used; the results were more favorable with the screen filter. Fibrin was considered to be one of the substances removable by the screen filter. HPLC analysis of the filtered and concentrated ascites, after passage through the screen filter, revealed a fraction corresponding to albumin. Intravenous injection of this fraction into rabbits caused fever. Although the screen filter cannot completely prevent fever on reinfusion of ascites, it appears useful to prevent fever in some patients.

Entities:  

Mesh:

Year:  1991        PMID: 1942641     DOI: 10.2169/internalmedicine1962.30.311

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  5 in total

1.  Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.

Authors:  Rumi Hanada; Naosuke Yokomichi; Chihiro Kato; Kazumi Miki; Sachiko Oyama; Tatsuya Morita; Ryoko Kawahara
Journal:  Support Care Cancer       Date:  2017-11-22       Impact factor: 3.603

2.  Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer.

Authors:  Osamu Maeda; Takafumi Ando; Kazuhiro Ishiguro; Osamu Watanabe; Ryoji Miyahara; Masanao Nakamura; Kohei Funasaka; Furukawa Kazuhiro; Yuichi Ando; Hidemi Goto
Journal:  Mol Clin Oncol       Date:  2014-07-04

3.  Continuous ascitic recirculation in severe ovarian hyperstimulation syndrome.

Authors:  D H Beck; S Massey; B L Taylor; G B Smith
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

4.  Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study.

Authors:  Yosuke Yamada; Keita Inui; Yuuta Hara; Kazuaki Fuji; Kosuke Sonoda; Koji Hashimoto; Yuji Kamijo
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379

5.  Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.

Authors:  Naosuke Yokomichi; Kengo Imai; Masaki Sakamoto; Masashi Horiki; Toshihiro Yamauchi; Satoru Miwa; Satoshi Inoue; Yu Uneno; Hidekazu Suzuki; Toru Wada; Yuri Ichikawa; Tatsuya Morita
Journal:  BMC Cancer       Date:  2022-02-28       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.